ATM

The PgX (Pharmacogenomic) Test examines a patient's inherited genes to detect variations that may impact how a drug is broken down, absorbed, and used within the body.

This test is particularly important for individuals with a family history of cancer, as it can help identify inherited cancer risks.

This test screens for 32 genes linked to a wide range of hereditary cancers, including but not limited to breast, colon, endometrium, stomach, urinary tract, ovary, pancreas, prostate, rectum, and other cancers. A positive result indicates a higher risk of developing certain cancers compared to the general population.

This test is particularly important for individuals with a family history of breast or other related cancers, as it can help identify increased risks for developing these conditions.